GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

FPA Crescent Fund Buys Arris Group, Thermo Fisher, Citigroup, Sells Pfizer Inc, eBay, Pharmerica

insider

gurufocus

332 followers
Steven Romick of FPA Crescent Fund just reported its fourth quarter portfolio. The fund has built impressive track record since inception and the size of the fund has grown tremendously. Over the past 5 years FPA Crescent Fund had a cumulative gain of 25.6%, while the S&P 500 index lost 3%. Over the past 10 years the fund gained an cumulative 125.6%, which the S&P 500 gained just 32%.

Steven Romick certainly sees a lot inflows as he is better known to financial community. He is the only Guru that reports short positions and his short is tracked in his portfolio.

This is the portfolio chart of Steven Romick. You can click on the legend of the chart to show/hide buys, sells, or holdings. Each ball on the chart represents a position in the portfolio. You can move your mouse on the balls to see the details of each position and click to see the details of all guru trades with this position.



As of 12/31/2011, FPA Crescent Fund owns 68 stocks with a total value of $4660.5 billion. These are the details of the buys and sells.

For the details of Steven Romick's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Steven+Romick

This is the sector weightings of his portfolio:

Not Assigned 28.3%
Consumer Services 19.4%
Health Care 12.7%
Oil & Gas 12.1%
Financials 11.6%
Technology 10.8%
Industrials 2.8%
Consumer Goods 2.2%


These are the top 5 holdings of Steven Romick

  1. CVS Caremark Cp (CVS) - 7,685,000 shares, 6.7% of the total portfolio. Shares added by 2.88%
  2. Aon Corp (AON) - 6,175,000 shares, 6.2% of the total portfolio. Shares reduced by 7.7%
  3. Wal-Mart Stores (WMT) - 4,655,000 shares, 6.0% of the total portfolio. Shares reduced by 0.43%
  4. Covidien Plc (COV) - 4,680,000 shares, 4.5% of the total portfolio. Shares added by 8.46%
  5. Microsoft Corp (MSFT) - 7,770,000 shares, 4.3% of the total portfolio.


New Purchase: Arris Group Inc (ARRS)

Steven Romick initiated holdings in Arris Group Inc. His purchase prices were between $9.91 and $11.52, with an estimated average price of $10.75. The impact to his portfolio due to this purchase was 0.8%. His holdings were 3,447,200 shares as of 12/31/2011. Arris Group, Inc. is an international communications technology company serving the broadband information transport industries. Arris Group Inc has a market cap of $1.38 billion; its shares were traded at around $11.59 with a P/E ratio of 17.7 and P/S ratio of 1.3. Arris Group Inc had an annual average earnings growth of 2.8% over the past 5 years.

New Purchase: Citigroup Inc (C)

Steven Romick initiated holdings in Citigroup Inc. His purchase prices were between $23.11 and $34.17, with an estimated average price of $27.82. The impact to his portfolio due to this purchase was 0.66%. His holdings were 1,172,320 shares as of 12/31/2011. Citigroup Inc., the global financial services company, has some two hundred million customer accounts and does business in more than hundred countries, providing consumers, corporations, governments, and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, and wealth management. Citigroup Inc has a market cap of $94.58 billion; its shares were traded at around $32.93 with a P/E ratio of 8.7 and P/S ratio of 1.2. The dividend yield of Citigroup Inc stocks is 0.1%.

New Purchase: Hollyfrontier (HFC)

Steven Romick initiated holdings in Hollyfrontier. His purchase prices were between $21.74 and $34.62, with an estimated average price of $27.24. The impact to his portfolio due to this purchase was 0.11%. His holdings were 226,116 shares as of 12/31/2011. HollyFrontier Corporation is engaged in refining petroleum. Hollyfrontier has a market cap of $7.09 billion; its shares were traded at around $33.14 with a P/E ratio of 6.5 and P/S ratio of 0.9. The dividend yield of Hollyfrontier stocks is 1.2%. Hollyfrontier had an annual average earnings growth of 19% over the past 10 years.

Added: Thermo Fisher (TMO)

Steven Romick added to his holdings in Thermo Fisher by 44.52%. His purchase prices were between $43.54 and $54.65, with an estimated average price of $48.38. The impact to his portfolio due to this purchase was 0.68%. His holdings were 2,295,000 shares as of 12/31/2011. Thermo Fisher Scientific is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. Thermo Fisher has a market cap of $21.43 billion; its shares were traded at around $56.43 with a P/E ratio of 13.6 and P/S ratio of 1.8. Thermo Fisher had an annual average earnings growth of 15% over the past 10 years.

Added: Walgreen Co (WAG)

Steven Romick added to his holdings in Walgreen Co by 30%. His purchase prices were between $30.74 and $35.34, with an estimated average price of $33.21. The impact to his portfolio due to this purchase was 0.35%. His holdings were 2,073,500 shares as of 12/31/2011. Walgreen Co. is a national retail pharmacy chain and considered the leader in innovative drugstore retailing. Walgreen Co has a market cap of $29.58 billion; its shares were traded at around $33.54 with a P/E ratio of 12.8 and P/S ratio of 0.4. The dividend yield of Walgreen Co stocks is 2.7%. Walgreen Co had an annual average earnings growth of 11.7% over the past 10 years. GuruFocus rated Walgreen Co the business predictability rank of 4.5-star.

Added: Covidien Plc (COV)

Steven Romick added to his holdings in Covidien Plc by 8.46%. His purchase prices were between $42.16 and $48.25, with an estimated average price of $45.07. The impact to his portfolio due to this purchase was 0.35%. His holdings were 4,680,000 shares as of 12/31/2011. Covidien PLC, formerly Covidien Ltd, is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. Covidien Plc has a market cap of $25.51 billion; its shares were traded at around $52.65 with a P/E ratio of 12.7 and P/S ratio of 2.2. The dividend yield of Covidien Plc stocks is 1.7%. Covidien Plc had an annual average earnings growth of 3.9% over the past 5 years.

Added: Cvs Caremark Cp (CVS)

Steven Romick added to his holdings in Cvs Caremark Cp by 2.88%. His purchase prices were between $32.97 and $41.16, with an estimated average price of $37.2. The impact to his portfolio due to this purchase was 0.19%. His holdings were 7,685,000 shares as of 12/31/2011. CVS/Caremark is the nation's premier integrated pharmacy services provider, combining one of the nation's pharmaceutical services companies with the country's largest pharmacy chain. Cvs Caremark Cp has a market cap of $57.36 billion; its shares were traded at around $44.53 with a P/E ratio of 15.7 and P/S ratio of 0.5. The dividend yield of Cvs Caremark Cp stocks is 1.5%. Cvs Caremark Cp had an annual average earnings growth of 10.9% over the past 10 years. GuruFocus rated Cvs Caremark Cp the business predictability rank of 3.5-star.

Added: Lowes Cos (LOW)

Steven Romick added to his holdings in Lowes Cos by 6.43%. His purchase prices were between $18.98 and $25.96, with an estimated average price of $22.77. The impact to his portfolio due to this purchase was 0.17%. His holdings were 5,050,000 shares as of 12/31/2011. Lowe's Companies Inc. is a retailer of home improvement products in the world, with specific emphasis on retail do-it-yourself and commercial business customers. Lowes Cos has a market cap of $34.02 billion; its shares were traded at around $27.34 with a P/E ratio of 17.2 and P/S ratio of 0.7. The dividend yield of Lowes Cos stocks is 2.1%. Lowes Cos had an annual average earnings growth of 7.8% over the past 10 years.

Reduced: Pfizer Inc (PFE)

Steven Romick reduced to his holdings in Pfizer Inc by 88.55%. His sale prices were between $17.33 and $21.83, with an estimated average price of $19.71. The impact to his portfolio due to this sale was -2.13%. Steven Romick still held 630,000 shares as of 12/31/2011. Pfizer Inc is a research-based, global pharmaceutical company that discovers and develops innovative, value-added products that improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. Pfizer Inc has a market cap of $162.81 billion; its shares were traded at around $21.26 with a P/E ratio of 9.1 and P/S ratio of 2.4. The dividend yield of Pfizer Inc stocks is 4.2%. Pfizer Inc had an annual average earnings growth of 1.2% over the past 10 years.

Reduced: Ebay Inc (EBAY)

Steven Romick reduced to his holdings in Ebay Inc by 48.55%. His sale prices were between $28.11 and $33.87, with an estimated average price of $31.08. The impact to his portfolio due to this sale was -0.24%. Steven Romick still held 355,000 shares as of 12/31/2011. eBay is one of the world's largest online trading communities. Ebay Inc has a market cap of $46.94 billion; its shares were traded at around $36.56 with a P/E ratio of 20.5 and P/S ratio of 4. Ebay Inc had an annual average earnings growth of 19.5% over the past 10 years. GuruFocus rated Ebay Inc the business predictability rank of 2.5-star.

Reduced: Pharmerica Corp (PMC)

Steven Romick reduced to his holdings in Pharmerica Corp by 25.52%. His sale prices were between $11.91 and $16.4, with an estimated average price of $15.04. The impact to his portfolio due to this sale was -0.03%. Steven Romick still held 235,800 shares as of 12/31/2011. PharMerica Corporation is an institutional pharmacy services provider dedicated to providing quality customer service and innovative pharmacy solutions to institutional customers and patients in long-term care settings. Pharmerica Corp has a market cap of $362.9 million; its shares were traded at around $12.38 with a P/E ratio of 10 and P/S ratio of 0.2. Pharmerica Corp had an annual average earnings growth of 18.6% over the past 5 years.

Here is the complete portfolio of Steven Romick. Also check out the Undervalued Stocks, Top Growth Companies, and High Yield stocks of Steven Romick.

About the author:

gurufocus
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.1/5 (16 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide